222 related articles for article (PubMed ID: 23607383)
1. [Incidence of erythrocyte alloimmunization in pregnant women in olomouc region].
Holusková I; Lubušký M; Studničková M; Procházka M
Ceska Gynekol; 2013 Jan; 78(1):56-61. PubMed ID: 23607383
[TBL] [Abstract][Full Text] [Related]
2. [Spontaneous antepartal RhD alloimmunization].
Studničková M; Holusková I; Durdová V; Kratochvílová T; Strašilová P; Marková I; Lubušký M
Ceska Gynekol; 2015 Dec; 80(6):401-4. PubMed ID: 26741153
[TBL] [Abstract][Full Text] [Related]
3. Immunological principle of development of red blood cell alloimmunization in pregnancy, hemolytic disease of the fetus and prevention of RhD alloimmunization in RhD negative women.
Roubalová L; Lubušký M
Ceska Gynekol; 2020; 85(6):408-416. PubMed ID: 33711901
[TBL] [Abstract][Full Text] [Related]
4. [Pregnant women alloimmunisation of non-RhD erythrocyte antigens: review article].
Petros M; L'ubuský M; Simetka O; Procházka M
Ceska Gynekol; 2010 Aug; 75(4):325-33. PubMed ID: 20925232
[TBL] [Abstract][Full Text] [Related]
5. Screening of RHD fetal genotype in RhD negative women.
Kratochvílová T; Böhmová J; Durdová V; Vodička R; Holusková I; Langová K; Lubušký M
Ceska Gynekol; 2020; 85(3):156-163. PubMed ID: 33562966
[TBL] [Abstract][Full Text] [Related]
6. Risk of maternal alloimmunization in Southern Pakistan - a study in a cohort of 1000 pregnant women.
Karim F; Moiz B; Kamran N
Transfus Apher Sci; 2015 Feb; 52(1):99-102. PubMed ID: 25532481
[TBL] [Abstract][Full Text] [Related]
7. The risk assessment study for hemolytic disease of the fetus and newborn in a University Hospital in Turkey.
Altuntas N; Yenicesu I; Himmetoglu O; Kulali F; Kazanci E; Unal S; Aktas S; Hirfanoglu I; Onal E; Turkyilmaz C; Ergenekon E; Koc E; Atalay Y
Transfus Apher Sci; 2013 Jun; 48(3):377-80. PubMed ID: 23619329
[TBL] [Abstract][Full Text] [Related]
8. Female alloimmunization with antibodies known to cause hemolytic disease.
Geifman-Holtzman O; Wojtowycz M; Kosmas E; Artal R
Obstet Gynecol; 1997 Feb; 89(2):272-5. PubMed ID: 9015034
[TBL] [Abstract][Full Text] [Related]
9. [Erythrocyte alloimmunization in pregnant women, clinical importance and laboratory diagnostics].
Holusková I; Lubušký M; Studničková M; Procházka M
Ceska Gynekol; 2013 Jan; 78(1):89-99. PubMed ID: 23607389
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of clinically significant red blood cell alloantibodies in pregnant women at a large tertiary-care facility.
Smith HM; Shirey RS; Thoman SK; Jackson JB
Immunohematology; 2013; 29(4):127-30. PubMed ID: 24689681
[TBL] [Abstract][Full Text] [Related]
11. Predictors of red cell alloimmunization in multitransfused Egyptian patients with β-thalassemia.
Hussein E; Ahmed Eldesoukey N; Rihan A; Kamal A
Arch Pathol Lab Med; 2014 May; 138(5):684-8. PubMed ID: 24786127
[TBL] [Abstract][Full Text] [Related]
12. Hemolytic Disease of the Fetus and Newborn: Modern Practice and Future Investigations.
Hendrickson JE; Delaney M
Transfus Med Rev; 2016 Oct; 30(4):159-64. PubMed ID: 27397673
[TBL] [Abstract][Full Text] [Related]
13. Red cell alloimmunization in RhD positive pregnant women and neonatal outcome.
Sankaralingam P; Jain A; Bagga R; Kumar P; Marwaha N
Transfus Apher Sci; 2016 Aug; 55(1):153-8. PubMed ID: 27324408
[TBL] [Abstract][Full Text] [Related]
14. Intravenous drug use is associated with alloimmunization in pregnancy.
Lappen JR; Stark S; Gibson KS; Prasad M; Bailit JL
Am J Obstet Gynecol; 2016 Sep; 215(3):344.e1-6. PubMed ID: 26996989
[TBL] [Abstract][Full Text] [Related]
15. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
[TBL] [Abstract][Full Text] [Related]
16. [Identification of alloantibodies and their associations: Balance sheet of 3 years at the Regional Center of Blood Transfusion in Rabat/Morocco and difficult in transfusion management].
Achargui S; Zidouh A; Abirou S; Merhfour FZ; Monsif S; Amahrouch S; El Ghobre A; El Halhali M; Temmara H; El Hryfy A; Motqi M; Satty A; Kandili M; Aghri M; Hajjout K; Benajiba M
Transfus Clin Biol; 2017 Nov; 24(4):422-430. PubMed ID: 28576386
[TBL] [Abstract][Full Text] [Related]
17. [Prevention of Rh (D) alloimmunization in Rh (D) negative women in pregnancy and after birth of Rh (D) positive infant].
L'ubuský M; Procházka M; Krejcová L; Vetr M; Santavý J; Kudela M
Ceska Gynekol; 2006 May; 71(3):173-9. PubMed ID: 16768042
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a solid-phase test for erythrocyte antibody screening of pregnant women, patients and blood donors.
Sallander S; Shanwell A; Aqvist M
Vox Sang; 1996; 71(4):221-5. PubMed ID: 8958646
[TBL] [Abstract][Full Text] [Related]
19. [Management of feto-maternal red cell allo-immunizations].
Bricca P; Guinchard E; Guitton Bliem C
Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546
[TBL] [Abstract][Full Text] [Related]
20. [Possibility to identify fetomaternal haemorrhage].
Studnicková M; L'ubuský M; Ordeltová M; Procházka M
Ceska Gynekol; 2010 Oct; 75(5):443-6. PubMed ID: 21374922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
